Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06739941 · ClinicalTrials.gov registry record · NA
Investigating the Tolerability of Oat Fiber (BG-OS) in Healthy Individuals
A NA study of Metabolic Health and Digestive Health, sponsored by One Bio.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06739941: Completed NA study of Metabolic Health and Digestive Health, sponsored by One Bio.
NCT06739941 is a NA study of Metabolic Health and Digestive Health that has completed, run by One Bio. The registered enrollment target is 60 participants, below the 50,139-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06739941, a NA study of Metabolic Health and Digestive Health, has completed, sponsored by One Bio.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this interventional study is to evaluate the tolerability and potential health benefits of oat fiber oligosaccharide (BG-OS) in healthy adults aged 18-70 years. The main questions it aims to answer are: * Does oat fiber dose impact gastrointestinal tolerability, as assessed by changes in symptoms using the Gastrointestinal Symptom Rating Scale (GSRS)? * Does oat fiber reduce postprandial glucose levels after a white rice challenge? Researchers will compare three groups receiving different doses of oat fiber (5 g, 10 g, and 20 g) to assess dose-related effects. Participants will: * Complete daily surveys on gastrointestinal symptoms, diet, energy, and sleep quality. * Use a continuous glucose monitoring device (CGM) to track glucose levels throughout the study. * Participate in standardized white rice challenge tests to measure glucose uptake during baseline and at one time point during study. * Provide stool samples during baseline and at the end of the study for gut microbiota analysis. * Undergo blood tests for biomarkers like CBC, CMP, and A1C at the beginning and end of the study.
Primary Outcome
Change in gastrointestinal symptoms as measured by mean total score on the Gastrointestinal Symptom Rating Scale (GSRS). The GSRS comprises 15 items, each rated on a Likert scale from 1 (no discomfort) to 7 (severe discomfort). Higher total scores indicate worse gastrointestinal symptoms
Conditions Studied
Interventions
- OTHER Oat fiber (BG-OS)
Study Locations (1)
California
- People Science Inc. - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-01-15 |
| Est. Completion | 2025-04-25 |
| Phase | NA |
What the finished NCT06739941 record still lists
NCT06739941 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 50,139-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Metabolic Health appearing as the primary indexed condition, and to 1 intervention - of which Oat fiber (BG-OS) is the first listed.
NCT06739941 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06739941 about?
NCT06739941 is a clinical study titled "Investigating the Tolerability of Oat Fiber (BG-OS) in Healthy Individuals". The goal of this interventional study is to evaluate the tolerability and potential health benefits of oat fiber oligosaccharide (BG-OS) in healthy adults aged 18-70 years. The main questions it aims to answer are: * Does oat fiber dose impact gastrointestinal tolerability, as assessed by changes ...
What is the current status of trial NCT06739941?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2025-01-15. Estimated completion is 2025-04-25.
What conditions does trial NCT06739941 study?
This clinical trial studies the following conditions: Metabolic Health, Digestive Health.
What interventions are being tested in trial NCT06739941?
The interventions under investigation include: Oat fiber (BG-OS) (OTHER).
Who is sponsoring clinical trial NCT06739941?
This trial is sponsored by One Bio, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06739941 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06739941's enrollment target sits among peer trials
60 6th of 10 higher than 3 of 10 other Metabolic Health trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions
RECRUITING · NA
-
Women's Hormonal and Metabolic Wellbeing Study
RECRUITING · NA
-
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
RECRUITING · NA
-
Study to Evaluate the Efficacy of an Avocado Dietary Supplement
ACTIVE NOT RECRUITING · NA
-
Impact of Protein Source and Polyphenol Complexation in Protein Bars on Metabolic Health
ACTIVE NOT RECRUITING · NA
-
Effects of a Synbiotic Supplement on Metabolic & Cognitive Outcomes Among Older Adults
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI